$1.3608
-0.0492[-3.49%]
Last update: 10:17AM Get Real Time Here
Cue Biopharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Cue Biopharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | CUE | Q1 | -$0.29 | -$0.29 | — | — | $187.00K | $1.00M | — | — | Get Alert |
04/08/2024 | PM | CUE | Q4 | -$0.37 | -$0.28 | -$0.28 | 0.00% | $151.00K | $1.71M | $1.82M | 6.49% | Get Alert |
11/03/2023 | PM | CUE | Q3 | -$0.31 | -$0.34 | -$0.24 | 29.41% | $68.00K | $1.13M | $2.10M | 85.84% | Get Alert |
08/09/2023 | PM | CUE | Q2 | -$0.37 | -$0.30 | -$0.29 | 3.33% | $26.00K | $1.21M | $1.38M | 14.21% | Get Alert |
05/09/2023 | PM | CUE | Q1 | -$0.44 | -$0.29 | -$0.29 | 0.00% | $1.00M | $1.95M | $187.00K | -90.41% | Get Alert |
03/21/2023 | PM | CUE | Q4 | -$0.25 | -$0.31 | -$0.37 | -19.35% | $8.25M | $100.00K | $151.00K | 51.00% | Get Alert |
11/14/2022 | PM | CUE | Q3 | -$0.41 | -$0.38 | -$0.31 | 18.42% | $2.40M | $440.00K | $68.00K | -84.55% | Get Alert |
08/04/2022 | PM | CUE | Q2 | -$0.33 | -$0.42 | -$0.37 | 11.90% | $2.74M | — | $26.00K | — | Get Alert |
05/10/2022 | PM | CUE | Q1 | -$0.41 | -$0.43 | -$0.44 | -2.33% | $1.55M | $3.05M | $1.00M | -67.21% | Get Alert |
03/16/2022 | PM | CUE | Q4 | -$0.36 | -$0.38 | -$0.25 | 34.21% | $475.00K | — | $8.25M | — | Get Alert |
10/27/2021 | PM | CUE | Q3 | -$0.34 | -$0.39 | -$0.41 | -5.13% | $704.00K | — | $2.40M | — | Get Alert |
08/17/2021 | PM | CUE | Q2 | -$0.38 | -$0.42 | -$0.33 | 21.43% | $1.07M | $1.06M | $2.74M | 158.40% | Get Alert |
05/17/2021 | PM | CUE | Q1 | -$0.48 | -$0.38 | -$0.41 | -7.89% | $900.00K | — | $1.55M | — | Get Alert |
03/16/2021 | PM | CUE | Q4 | -$0.37 | -$0.35 | -$0.37 | -5.71% | $1.05M | $1.33M | $475.00K | -64.29% | Get Alert |
11/09/2020 | PM | CUE | Q3 | -$0.31 | — | -$0.34 | — | $984.00K | — | $704.00K | — | Get Alert |
08/10/2020 | PM | CUE | Q2 | -$0.46 | — | -$0.38 | — | $1.05M | — | $1.07M | — | Get Alert |
05/19/2020 | PM | CUE | Q1 | -$0.54 | — | -$0.48 | — | $370.00K | — | $900.00K | — | Get Alert |
03/17/2020 | PM | CUE | Q4 | -$0.58 | -$0.40 | -$0.37 | 7.50% | $331.00K | $2.40M | $1.05M | -56.29% | Get Alert |
11/12/2019 | PM | CUE | Q3 | -$0.62 | — | -$0.31 | — | $449.00K | — | $984.00K | — | Get Alert |
Cue Biopharma (CUE) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on April 8, 2024 for Q4.
The Actual EPS was $-0.28, which hit the estimate of $-0.28.
The Actual Revenue was $1.8M, which beat the estimate of $1.7M.
Browse earnings estimates, EPS, and revenue on all stocks.